Suzetrigine, approved in 2025 2 for moderate to severe acute pain, is poised to change the acute pain management paradigm. Approval was based on 2 Phase 3 clinical trials evaluating drug efficacy vs ...

Twenty-five years after the World Trade Center attacks, cancer has become the defining health problem among survivors who breathed the toxic dust. The number wh ...

SAMA and SABA + SAMA use associated with increased risk for heart failure, arrhythmia, and mortality versus no use ...

Linear dose-response relationships seen for all associations; most were partially mediated by shorter sleep duration ...

HealthDay News — A Pennsylvania coroner has confirmed that measles killed one of two infants who died in the state last month, but federal health officials still are not counting either death in the ...

(HealthDay News) — From 2019 to 2026, there was an increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescribing for children aged 8 to 11 years without diabetes but with obesity, ...

B-cell-depleting therapy linked to lower relapse incidence, greater T2 lesion volume reduction compared with oral platform therapies ...

Experts outline strategies for primary care providers to differentiate between excessive video game use and gaming disorder ...

Odds of post-office visit image orders 188% higher with ordering clinician self-interpretation versus referring interpretation to a radiologist ...

HealthDay News — Autism spectrum disorder (ASD) diagnoses increased disproportionately among females after 2020, across age groups, while remaining stable or declining among males, according to a ...